News & Videos - GENUS ORD 10P

Genus plc (LSE: GNS), a leading global animal genetics company, is hosting a Capital Markets Event (CME) today at 10 AM ET, 3pm UK time. The CME will cover key strategic progress and initiatives being implemented to further strengthen Genus’s leadership in the animal genetics market. The presentations given by members of Genus's executive management will be made available on the Company website after the event at: https://www.genusplc.com/investors/results-reports-and-presentations/ ....

Genus plc (LSE: GNS), a global biotechnology leader in animal genetics, today reported interim results for the six-months period ending December 31, 2020, as well as provided a business update on recent corporate developments in its worldwide porcine and bovine genetics businesses. The full report has been made available on the Investors section of the Genus plc website. The Company will discuss its corporate, operational and financial highlights on a pre-recorded webcast, scheduled today,...

Genus plc (LSE: GNS), a global biotechnology leader in animal genetics, today reported continued strong performance across its operations for the six-months period ending December 31, 2020. The strong trading performance reported by the Company at its recent Annual General Meeting (AGM) on November 25, 2020 has continued through the first half of Genus’s financial year, and the adjusted profit before tax of the Group in actual currency is now expected to be within a range of £47.0m and...

Genus plc (LSE: GNS), a global biotechnology leader in animal genetics, today reported continued strong performance across its operations for the period from July 1, 2020 through November 24, 2020, coinciding with its Annual General Meeting today at 11:00 am GMT. The positive financial and operational momentum we achieved last year across the Genus Group has continued into our 2021 financial year. In the first four months of fiscal 2021 through October 31, 2020, we achieved further strong growth...

Vancouver, BC, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Genus Capital Management and Social Venture Connexion (SVX) today announced the launch of the Genus-SVX Impact Investment Counsel, a strategic partnership designed to address the challenges faced by foundations, high net worth individuals, charities, endowments and pension funds, in becoming impact investors. The Counsel seeks to mobilize $100 million in capital toward impact investments by 2020. "Many organizations and high net worth individuals...

VIDEO FINANCIAL REPORTING Why invest in is the first financial video platform where you can easily search through thousands of videos describing global ......

VIDEO FINANCIAL REPORTING Why invest in is the first financial video platform where you can easily search through thousands of videos describing global ......